WASHINGTON CAPITAL MANAGEMENT, INC - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
WASHINGTON CAPITAL MANAGEMENT, INC ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$570,860
-20.5%
8,500
-19.8%
0.52%
-13.9%
Q2 2023$717,726
+25.2%
10,6000.0%0.61%
+19.4%
Q1 2023$573,460
-9.5%
10,6000.0%0.51%
-12.5%
Q4 2022$633,986
+32.2%
10,6000.0%0.58%
+20.9%
Q3 2022$479,438
+0.6%
10,600
+24.7%
0.48%
+5.5%
Q2 2022$476,425
-21.2%
8,5000.0%0.46%
-8.2%
Q1 2022$604,435
+9.0%
8,5000.0%0.50%
+11.1%
Q4 2021$554,710
+1.3%
8,500
+16.4%
0.45%
-7.4%
Q3 2021$547,792
-3.9%
7,3000.0%0.48%
-29.7%
Q2 2021$570,000
-21.8%
7,300
-18.0%
0.69%
+1.9%
Q1 2021$729,000
-1.0%
8,9000.0%0.68%
-3.6%
Q4 2020$736,000
+27.3%
8,9000.0%0.70%
+18.4%
Q3 2020$578,000
+4.9%
8,9000.0%0.59%
-3.3%
Q2 2020$551,000
-3.3%
8,9000.0%0.61%
-14.5%
Q1 2020$570,000
-7.6%
8,9000.0%0.72%
+35.0%
Q4 2019$617,000
+9.6%
8,9000.0%0.53%
-3.6%
Q3 2019$563,000
+18.5%
8,900
+18.7%
0.55%
+2.0%
Q2 2019$475,000
+8.4%
7,5000.0%0.54%
+8.9%
Q1 2019$438,000
-21.9%
7,500
-17.6%
0.50%
-23.7%
Q4 2018$561,000
-20.9%
9,1000.0%0.65%
-4.4%
Q3 2018$709,000
+15.1%
9,1000.0%0.68%
+7.4%
Q2 2018$616,000
+18.5%
9,1000.0%0.63%
+21.3%
Q1 2018$520,0009,1000.52%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Paradice Investment Management LLC 798,931$53,656,2064.60%
Orchard Capital Management, LLC 135,466$9,097,8973.36%
Sivik Global Healthcare LLC 90,000$6,0443.05%
BERNZOTT CAPITAL ADVISORS 128,663$8,641,0072.98%
REINHART PARTNERS, LLC. 746,752$50,151,8932.60%
Integral Health Asset Management, LLC 250,000$16,790,0002.32%
Leeward Investments, LLC - MA 562,001$37,743,9871.93%
Copeland Capital Management, LLC 1,277,690$85,809,6651.84%
Magnetar Financial LLC 1,060,733$71,238,8281.82%
Advantage Alpha Capital Partners LP 122,252$8,210,4441.72%
View complete list of ENCOMPASS HEALTH CORP shareholders